Don't trust our CoA. Check it.
Every batch on our CoA page opens its report on the testing lab's own website, not ours. Here's the 60-second check ↓
6 tests per batch: identity, mass, purity, sterility, endotoxins, heavy metals.
Research use only.
https://t.co/4hlandUjEH
small mixup on the name, and it matters. natriuretic peptide receptor 1 is NPR1, also called NPR-A, the receptor ANP and BNP already use. NRP-1 is neuropilin-1, a different protein. they're testing an antibody that blocks NPR1, not a peptide drug
There still in no approved or highly effective treatment for postural orthostatic tachycardia syndrome (POTS), which can be debilitating.
Now there's hope with very encouraging results of a Phase 2 randomized trial: an antibody vs natriuretic peptide receptor 1 (NRP-1)
https://t.co/mts2NlvAYk
below the detection limit is not the same as zero. it means that assay could not see it at the concentration it can measure. a different test, or a lower limit, can change the result without anything in the sample changing
New PR: I have zero detectable inflammation
> 4 consecutive blood draws over 60 days
> each below detection limit
> 99.9th percentile
> while pushing my body hard to dunk
> 3 undetectable last year, 2 post psilocybin
> iron infusions acutely spike inflammation
Undetectable inflammation is very good.
High inflammation is very bad.
Meta analysis: highest inflammation group (83,995 adults) 75% higher all-cause mortality
#Advisory: Unauthorized peptides seized from Sage & Summit Wellness Co., in Ottawa, ON. Health Canada testing found bacteria in injectable peptide products: https://t.co/fiy3n5jJcu
comments on the HHS peptide docket closed last night
now comes the slow part. whether any of the six actually end up on the 503A bulks list is FDA rulemaking, and that's months, not weeks. i'd expect a lot of quiet before anything real moves
https://t.co/IutzH9F6Ga
comments on the HHS peptide docket close tonight, 11:59pm ET. HHS-OASH-2026-0496
as of friday morning the https://t.co/5ROyH6qOUW API was showing about 115 comments. the window doesn't decide the 503A bulks list, it just feeds the record while FDA does the actual rulemaking
https://t.co/Jh2xtct8m1
🚨HEALTH CANADA ALERT: Health Canada says it seized over 11,400 vials of unauthorized injectable peptides, and lab testing found bacteria in products from supplier Shanghai ERP Peptide Biotechnology. Advisory dated Nov 6 https://t.co/A58bCn8ctm
@bijans the state board push is the part i'd watch. the federal comment window closes friday but boards going after online dispensaries could move a lot faster than anything HHS decides
purity and sterility answer different questions and people keep treating them like synonyms
a high purity number says nothing about whether the vial is sterile. an endotoxin result says nothing about whether the sequence is what the label claims. you need the panel that matches the question you're actually asking
hijacking feels a bit strong? big tech brings compute, pharma still owns the wet labs and decades of failed compound data. not convinced either side gets far without the other https://t.co/RcG3DaqwFl
@endpts licensed from abbisko is the part worth noticing. china-originated molecules getting through FDA via western partners is getting pretty routine
another company saying it'll have all six HHS peptides on a prescription platform this month
precision peptide co announced nov 5. same week as a few others. the policy is barely a week old and the race to stand up supply is already the story
https://t.co/QnrtmtlEGQ